期刊文献+

急性粒细胞性白血病预后因素分析 被引量:1

Analysis of Prognostic Factors in Children with Acute Myeloid Leukemia
下载PDF
导出
摘要 目的 探讨儿童急性粒细胞性白血病 (AML)预后的相关因素。方法 回顾分析AML 84例患儿多种因素与 3年长期无病生存率 (EFS)的关系 ,并进行统计学分析。结果  3年EFS为 47.6 % ,统计学分析包括性别、FAB分型中M3型和M5型、ETO阳性M2 、PML RAR阳性M3型、1个月时骨髓未缓解、复杂异常型染色体等 ,其 3年EFS与对照组比较有显著性差异(P均 <0 .0 5)。结论 儿童AML的EFS与发病时多种因素有关。其中男童、M5型、1个月时骨髓未缓解、复杂异常型染色体为预后差的相关因素。ETO阳性M2 、PML RAR(+)的M3型预后好。 Objective To analyze prognostic factors in children with acute myeloid leukemia(AML).Methods Retrospective analyze the relationship between many factors of the diagnosed children with AML and their 3-years event-free survival(EFS).Statistics was analyzed with χ2 test.Results The 3-years EFS was 47.5%.According to the analysis of statistics,EFS of some children groups had statistical differences with their controls (P<0.05),which included sex,M 5 type,M 3 type,M 2 of ETO positive,M 3 of PML-RAR positive,not complete response(CR) to induction in 1 month,complex abnormal karytypes.Conclusions The EFS of children with AML have relationships with many factors.Male,M 5 type,not CR in 1 month and complex abnormal karytypes are bad factors to survive.M 2 type of ETO positive and M 3 type of PML-RAR positive are good factors.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2005年第1期24-25,共2页 Journal of Applied Clinical Pediatrics
关键词 儿童 白血病 粒细胞性 急性 预后因素 children leukemia myeloid,acute prognostic factors
  • 相关文献

参考文献6

二级参考文献9

共引文献39

同被引文献12

  • 1栾佐.儿童恶性淋巴瘤的诊断与治疗[J].实用儿科临床杂志,2005,20(1):1-2. 被引量:15
  • 2王菁,王丽敏.幽门螺杆菌相关性胃淋巴样组织淋巴瘤85例分析[J].新乡医学院学报,2005,22(4):358-359. 被引量:2
  • 3Armitage JO.Staging non-Hodgkin lymphoma[J].CA Cancer J Clin,2005,55(6):368-376.
  • 4Burkhardt B,Zimmermann M,Oschlies I,et al.The impact of age and gender on biology,clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence[J].Br J Haematol,2005,131(1):39-49.
  • 5Sonja G,Genadieva-Stavrik G.Prognostic model for aggressive non-Hodgkin lymphoma[J].Blood (ASH Annual Meeting Abstracts),2005,106:4689.
  • 6Kwak LW,Wilson M,Weiss LM,et al.Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas:the Stanford experiencel[J].J Clin Oncol,1991,9(8):1426-1431.
  • 7Escalon MP,Liu NS,Yang Y,et al.Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma:the M.D.Anderson Cancer Center experience[J].Cancer,2005,103(10):2091-2098.
  • 8Gallamini A,Stelitano C,Calvi R,et al.Peripheral T-cell lymphoma unspecified (PTCL-U):A new prognostic model from a retrospective multicentric clinical study[J].Blood,2004,103(7):2474-2479.
  • 9Campbell J,Seymour JF,Matthews J,et al.The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement[J].Eur J Haematol,2006,76(6):473-480.
  • 10Laughton SJ,Ashton LJ,Wan EK,et al.Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemia[J].J Clin Oncol,2006,23(10):2264-2271.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部